Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PTBP1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | RHOG | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | DENND4A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | TP53AIP1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | KRTAP1-5 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | COMMD5 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | GPRC5A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | NKTR | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | CYP27A1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PSME2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |